J2793 Rilonacept injection
Also known as: rilonacept, arcalyst
Injection of rilonacept (Arcalyst), an interleukin-1 (IL-1) receptor antagonist used for treatment of chronic inflammatory disorders.
In Plain Language
anti-inflammatory medication
Clinical Context
Used for cryopyrin-associated periodic syndromes (CAPS) and other IL-1-mediated autoinflammatory disorders.
RVU Information
CPT J2793 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J2793?
CPT J2793 (Rilonacept injection) is a J Codes (Drugs) code. Injection of rilonacept (Arcalyst), an interleukin-1 (IL-1) receptor antagonist used for treatment of chronic inflammatory disorders.
How is J2793 administered?
CPT J2793 is administered by a healthcare provider, typically via injection or infusion. Used for cryopyrin-associated periodic syndromes (CAPS) and other IL-1-mediated autoinflammatory disorders. It is used by Rheumatology, Internal Medicine.
When is CPT J2793 used?
Used for cryopyrin-associated periodic syndromes (CAPS) and other IL-1-mediated autoinflammatory disorders.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.